MedTrace Logo

Probiotic Use in Patients With Prior COPD Exacerbation

NCT02185092 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-05-23

No results posted yet for this study

Summary

The purpose of the study is to examine the hypothesis test that probiotics will reduce the frequency of exacerbation in patients with COPD.

Conditions

  • COPD
  • Obstructive Lung Disease

Interventions

DIETARY_SUPPLEMENT

Lactobacillus GG

probiotic supplement

OTHER

Sugar pill

placebo

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Karen S Allen, MD · OUHSC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-10-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185092 on ClinicalTrials.gov